Overview
ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. With our patients at the centre of all that we do, we help to accelerate the development of drugs and devices that save lives and improve quality of life. Our people are our greatest strength, are at the core of our culture, and the driving force behind our success. ICON people have a mission to succeed and a passion that ensures what we do, we do well.
Overview:
The Risk-based Study Management Principal role is responsible for timely and high-quality Risk-based Study Management (RBSM) strategy supporting the sponsor portfolio. This management-level RBSM Lead role is responsible for supporting the study-specific risk assessment process prior to leading the study teams through the periodic risk review process which includes ongoing assessment of Key Risk Indicators (KRIs) to identify issues and emerging risks in clinical trial variables (trends/outliers/poor performing sites) through the review of aggregate data. The RBSM Lead demonstrates an exceptional degree of technical and clinical trial expertise while working directly with the cross-functional study team to support the quality oversight of sites, countries, and studies both within the RBSM platforms via the study-specific analytics as well as the parallel process activities.
Responsibilities
What you will be doing:
MNCJobz.com will not be responsible for any payment made to a third-party. All Terms of Use are applicable.